Operating in France since 1961, MSD France, a research-based pharmaceutical company, is a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. MSD France aims to deliver global innovative health solutions to patients and healthcare professionals through prescription medicines in four major therapeutic areas - cardiometabolism, hospital, immunology, oncology - and digital solutions and services.
MSD eHealth Services' expertise is focused on bringing digital solutions that are helping healthcare professionals to better collaborate, share their expertise and improve the management of their patients throughout the health care pathway.
With its eHealth Services (Docvadis, Comuniti and Medelli) and expertise in the areas of facilitating best practices sharing between HCPs, simplifying collaboration, improving doctor-patient relationships, delivering high-quality patient information and enabling online medical appointment, MSD France envision to become a privileged eHealth partner and build solutions together with the HCPs, patients and engaged healthcare stakeholders.
BePATIENT, headquartered in Paris, France with operations in Europe, the United States and Australia, is a unique digital health company that is focused on patient empowerment and improving care pathway management for patients and providers.
The flexibility of our Patient-Centric digital platform allows us to market solutions in 4 main areas: Prevention, Acute Care, Chronic Care Management and Research.
Each solution provides the opportunity to engage and motivate patients to improve communication and adherence resulting in overall cost reduction as well as providing a positive impact on brand awareness and patient retention.
Specific to Research, Reach, was designed as an end-to-end digital solution to support patient participation in clinical trials from recruitment, through the conduct of the study, and into post-study engagement.
The BePATIENT Reach solution helps you to implement patient-friendly processes and fully-transparent follow-up processes for professionals, cutting cost, improving coordination, recruitment and increasing retention.
Epiconcept was created in 1996 to develop innovative information systems that address the pressing health challenges of today and tomorrow. Harnessing a combined expertise in both medical epidemiology and information technology, Epiconcept’s vocation is to improve the understanding of diseases and health systems by designing products that are intelligent, human and responsive for those managing public health programs.
With extensive experience driving complex international projects, Epiconcept gathers a 65-strong team of renowned doctors, epidemiologists, data scientists and IT specialists to deliver quality research, products, training and advise. Through this unique merger of health and technology, Epiconcept designs adapted and highly specialized tools for the development of health information systems that improve the prevention, detection and treatment of diseases. It further focuses on the creation of surveillance and alert networks, the management of cohorts, medical files, personalized case management, as well as the hosting and security of medical data and its transmission, exploitation and analysis to inform public health decision making.
Epiconcept works with partners such as the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC), various Ministries of Health (MOH), private institutes and NGOs such as Médecins Sans Frontières and the Red Cross.
In addition to funding, researchers are fundamentally in need of human resources to find volunteers willing to partake in their studies. Involving volunteers often turns out to be an arduous task likely to make some studies unfeasible.
Our goal at www.seintinelles.com is to boost the research process by making close collaboration between citizens and researchers easier, thanks to a collaborative research platform devoted to all forms of cancers in France.
More than 14,000 citizens already enrolled on Seintinelles, two and a half years after the site went live. Six research projects have already been completed, sometimes in less than 48 hours.
Eager to promote community research and health democracy, Seintinelles is striving to better involve citizens in medical research and provide researchers with groundbreaking tools to spur their research. Our main purpose is to boost research on cancer and make the results of those studies more quickly available.
of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology (e.g. multiple myeloma and prostate cancer), immunology (e.g. psoriasis), neuroscience (e.g. schizophrenia, dementia and pain), infectious disease (e.g. HIV/AIDS, hepatitis C and tuberculosis) and cardiovascular and metabolic diseases (e.g. diabetes). Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency.
The Janssen Health Policy Centre exists to increase collaboration with public and private healthcare partners to challenge perspectives and work together to address the most serious health issues facing society. By fostering close partnerships and alliances with other industry players, the academic world and public health organisations, our Janssen experts explore ways to collaborate more broadly and efficiently to secure better patient outcomes.
NODAL CLINICAL is a collaborative platform of Health data collection, Document workflow and Regulatory approval created for Pharmaceutical industry professionals, Biotechnologies, CROs or Health care professionals or Patients directly. We propose our solution on various segments and internationally: Clinical Trials, Therapeutic product Market Access and Patient Support Programs.
NODAL CLINICAL proposes a rupture in digital environment to its clients – a unique platform, transversal and integrated where each user accesses in real-time to her data of interest in complete security via her preferred support (smartphone, tablet, and website).
NODAL CLINICAL promotes long-term partnerships with its clients and adapts its solutions to their evolving needs at low costs. We engage ourselves in financial and operational risk mitigation in order to make the project success a common goal.
Founded in 2007 by Eric Sebban, VISIOMED GROUP is a company specializing in next-generation medical electronics. The laboratory develops and commercializes innovative health products in high-potential fields of medical self-diagnosis and wellness. VISIOMED is known for being the inventor of the ThermoFlash®, the first clinical infrared non-contact thermometer.
VISIOMED products incorporate innovation, technology and design to provide solutions for prevention and non-drug treatments focused on simplicity, comfort and the well-being of users.
In 2014, VISIOMED GROUP announced the launch of its “BewellConnect®” line of healthcare products, becoming the first medical electronics laboratory to penetrate the very high-potential market of the Internet of Things (IoT). Visiomed develops a truly integrated, connected and secure offering to serve the needs of both patients and health professionals, and aim to quickly become major key player in the global deployment of connected telemedicine and telehealth solutions.
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare.
With a presence in more than 100 countries and industrial sites in more than 40 countries, our industrial network, know-how and teams deliver health solutions to millions of individuals with high quality and maximum safety, regardless wherever they are manufactured. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.
Keyrus Biopharma, member of the international group Keyrus, is a global mid-size full-service Contract research organization (CRO) providing pharmaceutical, biotechnology, nutritional and medical device industries with a broad range of clinical research services from early- to late-stage clinical development, including project management, clinical monitoring, scientific and medical support, site management, biostatistics, data management, product safety, quality assurance, regulatory affairs, and medical writing.
Created in 1998, Keyrus Biopharma (KBP) with a workforce of more than 300 employees is located in France (Paris, Nantes), in Belgium (Lasne, Mont Saint-Guibert), in other western European countries (UK, Spain, Germany, Italy...), Tunisia (Tunis), in Lebanon (Beirut) and in North America (US and Canada).
We provide our customers with experienced staff (Insourcing) and offer flexible offsite and/or nearsite resources solutions (Functional Services - center of services dedicated to our clients) in all various areas of clinical development (biometry, pharmacovigilance, medical writing,..).
Since 2013, our IT and Research teams offer their expertise in bioinformatics, biostatistics and biology to make Life&Soft your key partner to reach your Research and Diagnosis goals in Health Sciences.
We are building bioinformatics pipelines to perform Next Generation Sequencing analysis. Our innovative applications provide valuable, accurate and high quality results from biological samples for diagnosis purposes. We also offer to support your clinical study analysis challenges by driving the analysis remotely or on site using our custom tools dedicated to your needs.
We are working with pharmaceutical, cosmetics and diagnosis companies, promoting long-term partnerships to find innovative, robust and specific solutions. Life&Soft built IT consulting partnerships with scientific editors to complete our development offer from the open-source world to commercial softwares.
Our interdisciplinary team is flexible and reactive. We will deliver the best services to fit with your needs.
Since 2010, at SANOÏA we are the Digital Experts in Patients’ Real Life.
Today, more than 50 000 patients with 14 different languages in 17 countries are using SANOÏA platform with confidence every month on their computers, tablets or smartphones to measure and report the health, disease, or treatment outcome required by their Clinical Research.
Our customers are Public or Private organizations with high digital ambitions for their health outcomes. They require a platform that accounts to preferences, is agile to better target and is trustable to be inclusive.
As a BPI France funded company, we are committed to innovation and to design new solutions for the changing needs in Clinical Trials.
Our team has a strong publication practice in the e-health and m-health domain: this year we will be publishing data in the areas of Internet of Things for Research use and the patient/physician dialog impact with m-health quantified-self tool.